BIO.News Newsletter

Today, we have good news from Oregon on Accelerated Approval, and what USDA’s doing to advance ag biotech in response to climate change. Meanwhile, we’re awaiting news from Capitol Hill regarding the reauthorization of SBIR/STTIR and PDUFA any moment now, with passage of both expected before the Sept. 30 deadline. (764 words, 3 minutes, 49 seconds)

The Biden administration released a food strategy ahead of today’s White House food security conference—we have details and how biotech can help. Plus, how governments are tackling non-communicable diseases and promising news from an Eisai and Biogen Alzheimer’s trial. (635 words, 3 minutes, 10 seconds)

We have more on the problems with the 340B program and the growing calls for the U.S. to take action on Mexico's GM corn ban. Plus, work continues on the Continuing Resolution before government funding expires on Friday evening. (671 words, 3 minutes, 21 seconds)And don't forget to listen to the latest I am BIO podcast exploring society's impending data storage problem and how DNA is being used to fix it. Listen now on Apple, Google, and Spotify.

BIO’s calling out the inconsistency between Biden’s new biotech EO and U.S. support for an expanded COVID IP waiver—plus, the Dept. of Energy released a roadmap to achieve major SAF and emissions goals. (672 words, 3 minutes, 21 seconds)

Ending the week with USDA nominee Alexis Taylor’s hearing at the Senate Ag Committee, BIO’s webinar on the impacts of the new drug price controls—and a deal on prescription drug user fees. Enjoy the weekend. (883 words, 4 minutes, 24 seconds)

Today we look at the investment landscape for sickle cell disease and an alarming new climate report that shows the need for biotech solutions, plus two brand-new reports showing both progress and setbacks in fighting cancer and other non-communicable diseases. (685 words, 3 minutes, 25 seconds)

Tons of news: SBIR/STTR bill passed the Senate and goes to the House (thanks in part to BIO advocacy), Ways & Means rejected a Resolution of Inquiry on the WTO’s IP waiver (see the extended Beltway Report), and we’re tweeting up a storm for Fungal Disease Awareness Week. (698 words, 3 minutes, 29 seconds) Don’t forget to join today’s webinar on the drug provisions of the Inflation Reduction Act—register here.

The House Ways & Means Committee is marking up a resolution that asks questions about the Biden administration’s policy regarding the WTO TRIPS waiver, and we launch the new season of the I am BIO Podcast with a fascinating episode about data storage with synthetic DNA. (793 words, 3 minutes, 57 seconds)

We take a deep dive on 340B programs—plus, look at the largest ever outbreak of bird flu in the UK and what Biden said yesterday about COVID-19. (724 words, 3 minutes, 37 seconds)

Federal officials discussed the state of the monkeypox outbreak and USDA greenlights a big purple tomato—plus, lawmakers are expected to work on FDA user fee reauthorization through the weekend. (713 words, 3 minutes, 33 seconds)